Cadence Pharmaceuticals, Inc. Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen; PDUFA Goal Date Extended by Three Months
11/13/2009 6:37:12 AM
More...
|
Cadence Pharmaceuticals, Inc. Reports Third Quarter 2009 Financial Results
11/6/2009 10:11:17 AM
More...
|
Cadence Pharmaceuticals, Inc.' CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
10/21/2009 8:36:03 AM
More...
|
Cadence Pharmaceuticals, Inc. President, CEO and Director to Ring The NASDAQ Stock Market Opening Bell
10/5/2009 10:39:35 AM
More...
|
Cadence Pharmaceuticals, Inc. to Webcast October 7th Analyst Day
9/30/2009 11:02:54 AM
More...
|
Cadence Pharmaceuticals, Inc. to Present at Two Investment Conferences During the Month of September 2009
9/10/2009 9:51:28 AM
More...
|
Cadence Pharmaceuticals, Inc.'s CEO Theodore Schroeder to Present at the Canaccord Adams Global Growth Conference in Boston on August 11, 2009
8/5/2009 8:59:21 AM
More...
|
Cadence Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2009 Financial Results on August 5, 2009
7/30/2009 9:59:49 AM
More...
|
Cadence Pharmaceuticals, Inc. Says Pain Drug Gets Priority Review Status
7/15/2009 6:56:55 AM
More...
|
Cadence Pharmaceuticals, Inc. Announces Appointment of Scott Byrd as Chief Commercial Officer
6/22/2009 12:23:50 PM
More...
|
|